Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth

MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended30 June 2025. All figures are in USD unless stated otherwise. H1 2025 key results[1] Group performan...

2025-08-21 08:23 3220

Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning

HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK; referred to collectively with its subsidiaries as the "Group" ), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused appro...

2025-08-20 22:14 6052

DKSH Healthcare Establishes Industry Benchmark in Carbon Emissions Tracking in Thailand

DKSH Business Unit Healthcare has reached a significant milestone in building a more sustainable healthcare supply chain by successfully tracking carbon emissions across its value chain through a collaboration with UOB FinLab's GreenTech Accelerator and Smart Tradzt inThailand. This achievement a...

2025-08-20 12:00 3115

DKSH Healthcare Establishes Industry Benchmark in Carbon Emissions Tracking in Thailand

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

BEIJING, Aug. 20, 2025 /PRNewswire/ -- From August 15-17, the 31st China International Medical Equipment Exhibition and Scientific Conference (China-Hospeq 2025) was held inBeijing. Vital Materials officially launched the VITA Genesis,China's fully proprietary Photon Counting CT (PCCT) scanner, ...

2025-08-20 10:45 2777

Vital Materials Released Quantum Flux Photon Counting CT (PCCT) Full Vertical Integration Technology

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

CAMBRIDGE, Mass., Aug. 20, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based o...

2025-08-20 08:00 4081

ARC Therapies Advances Gut Microbiome Research with YB328 Toward Clinical Application

Investigating Its Role as an Immune Adjuvant in Cancer Immunotherapy TOKYO, Aug. 20, 2025 /PRNewswire/ -- ARC Therapies Inc. (Head Office: Shinjuku,Tokyo; President & CEO: Rami Suzuki), a certified startup from the National Cancer Center Japan, has initiated research ofYB328, a newly identified ...

2025-08-20 07:00 2329

LabConnect Launches LabConnector™ to Streamline Lab Data Integration

New service ensures faster, more accurate data delivery to clients JOHNSON CITY, Tenn., Aug. 19, 2025 /PRNewswire/ -- LabConnect, LLC, a global leader in central laboratory services for clinical trials, today announced the launch of LabConnector™, a powerful new technology solution that transform...

2025-08-19 21:15 1787

Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC

CHENGDU, China, Aug. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) announced that clinical data from a Phase II study evaluating novel TROP2 antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) in combination with PD-L1 monocl...

2025-08-19 20:09 2059

Nilesh Shah joins Illumina as Head of Region, AMEA

SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment ofNilesh Shah as Head of Region, AMEA, effective immediately. ...

2025-08-19 14:14 2575

Nilesh Shah joins Illumina as Head of Region, AMEA

Antengene's ATG-022 (CLDN18.2 ADC) Granted Breakthrough Therapy Designation for the Treatment of Gastric/Gastroesophageal Junction Adenocarcinoma

SHANGHAI and HONG KONG, Aug. 19, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic ma...

2025-08-19 13:26 2226

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

* Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the real world.[1] * In the recent HARMONIE trial findings, Beyfortus reduced RSV hospitalisation...

2025-08-19 11:00 3160

RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries

YANTAI, China, Aug. 19, 2025 /PRNewswire/ -- RemeGen Co., Ltd. (Stock Code: 688331.SH/09995.HK, "RemeGen"), a leading Chinese biopharmaceutical company, announced today that it has entered into an agreement with Santen Pharmaceutical (China) Co., Ltd. ("Santen China"), a wholly-owned subsidiary o...

2025-08-19 08:00 2663

openRxiv names Dr. Tracy Teal first CEO to advance open science

Scientist and nonprofit leader who previously led The Carpentries and Dryad to lead the organization that oversees bioRxiv and medRxiv. DAVIS, Calif., Aug. 19, 2025 /PRNewswire/ -- openRxiv announced today that after an extensive international search, its Board of Directors has appointed Dr.Trac...

2025-08-19 00:00 1800

Ansell Receives Frost & Sullivan's 2025 Global Sustainable Hospital Supplies Company of the Year Award

Ansell is recognised for its leadership in hospital supply sustainability, visionary innovation, and customer impact on a global scale. SAN ANTONIO, Aug. 18, 2025 /PRNewswire/ -- Frost & Sullivan, a leader in the information and growth advisory industry, has awarded the title of "2025 Global Sus...

2025-08-18 22:00 2060

Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform

Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost adherence, retention and deliver breakthrough health outcomes with cost savings DUBLIN, Aug. 18, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, today ann...

2025-08-18 21:30 2750

Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).

* This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. * DXVX is taking the lead in business development, with several companies in the due diligence stage, and additional deals are anticipated. SEOUL, South...

2025-08-18 21:00 2399

KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS

* Revenue reached approximately RMB950.4 million, with total commercial sales RMB309.8million, representing a significant increase in proportion * Research and development expenses was approximately RMB611.5 million * Loss for the period was RMB145.2 million; adjusted loss for the period[1] ...

2025-08-18 18:29 2903

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

NEW DELHI, Aug. 18, 2025 /PRNewswire/ -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one ofIndia's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas

2025-08-18 18:23 1862

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

Next Generation Refractive Surgery to LASIK and SMILE Now Available for Clinical Review

Pioneer surgeon Dr Natasha Lim is among the first in Singapore to offer Smooth Incision Lenticular Keratomileusis (SILK) procedure in their clinics. SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- Dr. Natasha Lim, an internationally renowned surgeon in Ophthalmology, has introduced an alternative to est...

2025-08-18 11:00 2220

$Next Generation Refractive Surgery to LASIK and SMILE Now Available for Clinical Review$

Herbalgy, Pain Management Expert, Harnesses the Wisdom of Traditional Chinese Medicine to Safeguard Hong Kong's Health, Proudly Appoints Moses Chan as Brand Ambassador

Download high-resolution images: https://cutt.ly/IrGBefFJ HONG KONG, Aug. 18, 2025 /PRNewswire/ -- As Hong Kong's pain management expert, Herbalgy has been serving the community since its founding in 1999. For over 25 years, the brand has been dedicated to promoting he...

2025-08-18 10:00 2349

1 ... 83 84 858687 88 89 ... 541